Ligand Pharmaceuticals
Ligand Pharmaceuticals Incorporated, a biotechnology company, focuses on the discovery and early-stage development of pharmaceuticals for.
Launch date
Employees
Market cap
CAD2.6b
Enterprise valuation
CAD2.3b (Public information from Sep 2024)
Share price
$105.01 LGND
San Diego California (HQ)
No columns specified